Koichi Higashimori
-
- Renin-Angiotensin System Studies 24
-
- Hormonal Regulation and Hypertension 17
- Physiology top 10%
- Nitric Oxide and Endothelin Effects 6
- Endocrine and Autonomic Systems top 10%
- Pharmacology top 10%
-
- Receptor Mechanisms and Signaling 9
-
- Cardiovascular, Neuropeptides, and Oxidative Stress Research 4
-
- Eicosanoids and Hypertension Pharmacology 3
-
- Neuropeptides and Animal Physiology 3
-
- Nutrition, Genetics, and Disease 2
- Co-authors
- Toshio OgiharaHiroshi MikamiMasahiro NaganoMitsuaki NakamaruTadashi InagamiJitsuo HigakiHiromi RakugiYoshikatsu Tabuchi
- Journals
- Biochemical and Biophysical Research Communications (6 papers)Hypertension (5 papers)Journal of Hypertension (4 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Koichi Higashimori
36 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 94
- Cardiology and Cardiovascular Medicine 700
- Endocrinology, Diabetes and Metabolism 385
- Physiology 276
- Endocrine and Autonomic Systems 59
- Pharmacology 97
Countries citing papers authored by Koichi Higashimori
This map shows the geographic impact of Koichi Higashimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Higashimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Higashimori more than expected).
Fields of papers citing papers by Koichi Higashimori
This network shows the impact of papers produced by Koichi Higashimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Higashimori. The network helps show where Koichi Higashimori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Koichi Higashimori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 6 | |
| 2 | 1994 | 3 | |
| 3 | 1994 | 17 | |
| 4 | 1994 | 14 | |
| 5 | Antihypertensive efficacy of FK906, a novel human renin inhibitor. | 1993 | 8 |
| 6 | 1993 | 19 | |
| 7 | 1993 | 111 | |
| 8 | 1992 | 43 | |
| 9 | Effect of manidipine, a novel calcium channel blocker, on quality of life in hypertensive patients. | 1992 | 18 |
| 10 | 1991 | 83 | |
| 11 | 1991 | 9 | |
| 12 | 1991 | 19 | |
| 13 | 1990 | 171 | |
| 14 | 1990 | 38 | |
| 15 | 1988 | 13 | |
| 16 | 1988 | 2 | |
| 17 | 1988 | 6 | |
| 18 | 1988 | 79 | |
| 19 | 1987 | 11 | |
| 20 | 1987 | 43 |
About Koichi Higashimori
Koichi Higashimori is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Biochemistry, Physiology and Behavioral Neuroscience, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (24 papers), Hormonal Regulation and Hypertension (17 papers), Receptor Mechanisms and Signaling (9 papers), Nitric Oxide and Endothelin Effects (6 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Neuropeptides and Animal Physiology (3 papers) and Nutrition, Genetics, and Disease (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (700 citations), Endocrinology, Diabetes and Metabolism (385 citations), Physiology (276 citations), Endocrine and Autonomic Systems (59 citations) and Pharmacology (97 citations). Koichi Higashimori has collaborated with scholars based in Japan and United States. Frequent co-authors include Toshio Ogihara, Hiroshi Mikami, Masahiro Nagano, Mitsuaki Nakamaru, Tadashi Inagami, Jitsuo Higaki, Hiromi Rakugi, Yoshikatsu Tabuchi, Hiroshi Mikami and Toshio Ogihara. Their work appears in journals such as Biochemical and Biophysical Research Communications, Hypertension, Journal of Hypertension, Clinical and Experimental Pharmacology and Physiology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.